Cary Street Partners Investment Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Buy
4,188
+1,284
+44% +$104K 0.07% 283
2026
Q1
$252K Sell
2,904
-130
-4% -$12.5K 0.06% 304
2025
Q4
$291K Buy
3,034
+629
+26% +$61.1K 0.08% 253
2025
Q3
$229K Buy
2,405
+214
+10% +$19.7K 0.1% 237
2025
Q2
$191K Buy
2,191
+124
+6% +$10.5K 0.09% 252
2025
Q1
$186K Buy
2,067
+329
+19% +$29.4K 0.11% 224
2024
Q4
$139K Sell
1,738
-43,282
-96% -$3.75M 0.09% 235
2024
Q3
$4.05M Buy
45,020
+2,457
+6% +$207K 0.15% 157
2024
Q2
$3.35M Buy
42,563
+8,204
+24% +$673K 0.14% 176
2024
Q1
$2.99M Buy
34,359
+32
+0.1% +$2.73K 0.13% 184
2023
Q4
$2.83M Buy
34,327
+985
+3% +$75.1K 0.13% 180
2023
Q3
$2.61M Buy
33,342
+22,216
+200% +$1.86M 0.14% 183
2023
Q2
$980K Sell
11,126
-2,943
-21% -$253K 0.06% 260
2023
Q1
$1.13M Sell
14,069
-528
-4% -$43K 0.08% 227
2022
Q4
$1.13M Sell
14,597
-4,181
-22% -$339K 0.08% 220
2022
Q3
$1.52M Buy
18,778
+1,907
+11% +$171K 0.12% 182
2022
Q2
$1.51M Buy
16,871
+11,469
+212% +$1.16M 0.13% 171
2022
Q1
$601K Buy
5,402
+592
+12% +$62.5K 0.17% 135
2021
Q4
$498K Buy
4,810
+43
+0.9% +$4.98K 0.14% 153
2021
Q3
$598K Buy
4,767
+85
+2% +$11K 0.2% 118
2021
Q2
$581K Buy
4,682
+2,815
+151% +$353K 0.19% 119
2021
Q1
$221K Sell
1,867
-4,191
-69% -$491K 0.09% 191
2020
Q4
$710K Buy
6,058
+3,733
+161% +$411K 0.14% 148
2020
Q3
$242K Buy
+2,325
New +$233K 0.05% 240

Other funds holding MDT

Cary Street Partners Investment Advisory's MDT Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Medtronic (MDT) stake by 44% in Q2 2026, buying an estimated $104K and bringing the position to 4,188 shares worth $328K. The position accounts for 0.07% of the portfolio, ranked #283.

Cary Street Partners Investment Advisory first reported a position in MDT in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.05M in Q3 2024. 1,574 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cary Street Partners Investment Advisory held 4,188 shares of Medtronic worth $328K as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 1,284 Medtronic shares in Q2 2026, an estimated $104K.
  • Medtronic made up 0.07% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #283 holding.
  • Cary Street Partners Investment Advisory first reported a position in Medtronic in Q3 2020 and has held it in 24 quarters since.
  • Cary Street Partners Investment Advisory's Medtronic position peaked at $4.05M in Q3 2024.
  • 1,574 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.